KDLY Stock Surges 29.94% Amid Merger with Bitcoin Firm
By ATTN Desk · Editorial oversight: Sean Han
KINDLY MD INC (KDLY) Overview
Introduction to the Company
KINDLY MD INC (NASDAQ: KDLY), founded in 2019 and headquartered in Salt Lake City, Utah, is a publicly traded healthcare services and data company. The firm integrates traditional primary care and pain management with behavioral health and alternative therapies, including medical cannabis recommendations and weight-loss programs. As of May 21, 2025, KDLY shares are trading at $19.78, reflecting a 29.94% increase in the session.
Corporate Structure
- Employees: 51–200 (LinkedIn)
- Founders & Leadership:
- Tim Pickett, MPAS-C, Founder & CEO
- Clinical Footprint:
- Four outpatient clinic locations across Utah
- Telemedicine services available nationwide
- Service Lines:
- Primary Care (preventative care, lab work)
- Integrated Behavioral Health (CBT, functional therapy)
- Pain Treatment & Injury Clinic
- Medical Cannabis Evaluation & Education
- GLP-1-based Weight-Loss Programs
Developments and News
- May 16, 2025: Filed Form 8-K (Items 5.02, 8.01, 9.01) reporting corporate governance updates.
- May 18, 2025: Majority stockholder consent delivered approving a merger agreement with Nakamoto Holdings Inc, a Bitcoin-native holding company.
- May 19, 2025: Filed Prospectus Supplement (Form 424B3) detailing:
- Exercise of 2,059,811 warrants into common shares
- Resale of 82,310 shares by warrant holders
- Reference price as of May 16, 2025: $12.95 per share; warrants at $7.37 each
- May 20, 2025: Filed Form 8-K (Items 5.07, 7.01, 9.01) disclosing material events and management changes.
Financial and Strategic Analysis
Stock and Market Metrics (as of May 21, 2025)
| Metric | Value |
|---|---|
| Share Price | $19.78 |
| Daily Change | +29.94% |
| Volume | 2,491,665 |
| 52-Week Range | $0.65 – $31.45 |
| Market Capitalization | $119.4 million |
| Average Daily Volume (3 mo) | 2,550,095 |
| Price/Sales (TTM) | 37.10 |
| Price/Book (MRQ) | 59.94 |
Income Statement & Balance Sheet Highlights (TTM)
| Item | Value |
|---|---|
| Revenue | $2.47 million |
| Net Income/(Loss) | –$4.37 million |
| EPS (TTM) | –$0.73 |
| Profit Margin | –177.02% |
| Total Cash (MRQ) | $1.14 million |
| Total Debt/Equity (MRQ) | 43.58% |
- Revenue Mix: Primarily from clinic services, telemedicine, and educational programs.
- Profitability: Negative net margin reflects ongoing investments in clinical expansion and research and development.
- Liquidity: With cash reserves of $1.14 million and operating losses, the company has limited cash runway; debt-to-equity stands at 43.58%.
Strategic Considerations
- Integrated Care Model: Combining physical, mental, and alternative therapies aims to address the opioid epidemic and chronic conditions.
- Telemedicine Expansion: Enhances access to services beyond Utah.
- Capital Raising: Warrant exercises in May 2025 are expected to generate additional funding.
- Bitcoin Treasury Strategy: Following the merger with Nakamoto Holdings, the company intends to allocate part of its treasury to Bitcoin.
Market Position and Industry Context
- Competitive Landscape: KDLY operates at the intersection of primary care, behavioral health, and alternative medicine—sectors experiencing increased adoption of telehealth and patient-centric models.
- Regulatory Environment: Subject to state medical licensing, telehealth regulations, and cannabis prescribing rules, particularly in Utah.
- Addressable Market: U.S. outpatient care market; growing demand for integrated pain management and medication-assisted treatment.
- Peers & Comparables: Other small-cap healthcare services providers, medical cannabis clinics, and telehealth platforms.
tl;dr
KDLY shares rose 29.94% on May 21, 2025, to $19.78 following the approval of a merger with Nakamoto Holdings, which involves a Bitcoin treasury strategy. In mid-May, the company filed reports including two Form 8-Ks and a Form 424B3 prospectus covering governance updates and warrant exercises (2.06 million shares). TTM revenue is reported at $2.47 million against a net loss of $4.37 million, with cash on hand at $1.14 million. The merger with Nakamoto is anticipated to support KDLY’s integrated healthcare and telemedicine expansion.